CheyneStokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure

252Citations
Citations of this article
123Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims The aim of this first large-scale long-term study was to investigate whether obstructive sleep apnoea (OSA) and/or central sleep apnoea (CSA) are associated with an increased risk of malignant cardiac arrhythmias in patients with congestive heart failure (CHF). Methods and resultsOf 472 CHF patients who were screened for sleep disordered breathing (SDB) 6 months after implantation of a cardiac resynchronization device with cardioverter-defibrillator, 283 remained untreated [170 with mild or no sleep disordered breathing (mnSDB) and 113 patients declined ventilation therapy] and were included into this study. During follow-up (48 months), data on appropriately monitored ventricular arrhythmias as well as appropriate cardioverter-defibrillator therapies were obtained from 255 of these patients (90.1). Time period to first monitored ventricular arrhythmias and to first appropriate cardioverter-defibrillator therapy were significantly shorter in patients with either CSA or OSA. Forward stepwise Cox models revealed an independent correlation for CSA and OSA regarding monitored ventricular arrhythmias [apnoeahypopnoea index (AHI) <5 h-1: CSA HR 2.15, 95 CI 1.403.30, P < 0.001; OSA HR 1.69, 95 CI 1.641.75, P 0.001; AHI <15 h-1: CSA HR 2.06, 95 CI 1.403.05, P < 0.001; OSA HR 1.69, 95 CI 1.142.51, P 0.02] and appropriate cardioverter-defibrillator therapies (AHI <5 h-1: CSA HR 3.24, 95 CI 1.865.64, P < 0.001; OSA HR 2.07, 95 CI 1.143.77, P 0.02; AHI <15 h-1: CSA HR 3.41, 95 CI 2.105.54, P < 0.001; OSA HR 2.10, 95 CI 1.173.78, P 0.01). Conclusion In patients with CHF, CSA and OSA are independently associated with an increased risk for ventricular arrhythmias and appropriate cardioverter-defibrillator therapies. Published on behalf of the European Society of Cardiology. All rights reserved. © 2010 The Author.

Cite

CITATION STYLE

APA

Bitter, T., Westerheide, N., Prinz, C., Hossain, M. S., Vogt, J., Langer, C., … Oldenburg, O. (2011). CheyneStokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. European Heart Journal, 32(1), 61–74. https://doi.org/10.1093/eurheartj/ehq327

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free